Business
Glenmark Pharmaceuticals Limited Press Release Jul 06 2026
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 06, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Olanzapine for Injection, 10 mg/vial, Single-Dose Vial".
About this update from Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 06, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Olanzapine for Injection, 10 mg/vial, Single-Dose Vial". View Attachment
View stock analysis, news, and events for Glenmark Pharmaceuticals Limited